| 中文名 | 2-硫代-2’-脱氧胸苷 |
|---|---|
| 英文名 | 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-2-sulfanylidenepyrimidin-4-one |
| 中文别名 |
1-((2R,4S,5R)-4-羟基-5-(羟甲基)四氢呋喃-2-基)-5-甲基-2-硫代-2,3-二氢嘧啶-4(1H)-酮
2-硫代胸苷 |
| 英文别名 |
1-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one
2-THIOTHYMIDINE 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-2-sulfanylidene-1,2,3,4-tetrahydropyrimidin-4-one 2-thiothymidine 2-Thio-desoxythymidin Thymidine,2-thio Thymidine, 2-thio 2'-deoxy-5-methyl-2-thiouridine 1-(2-Deoxy-b-D-erythro-pentofuranosyl)-5-methyl-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone 1-[(2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-2-sulfanylidenyrimidin-4-one 2-Thio-2'-deoxythymidine 2-Thiothymidin |
| 描述 | 2-硫代胸苷是嘌呤核苷类似物。嘌呤核苷类似物具有广泛的抗肿瘤活性,靶向惰性淋巴系统恶性肿瘤。这一过程中的抗癌机制依赖于抑制DNA合成、诱导细胞凋亡等[1]。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 密度 | 1.52 g/cm3 |
|---|---|
| 分子式 | C10H14N2O4S |
| 分子量 | 258.29 |
| 精确质量 | 258.06700 |
| PSA | 119.57000 |
| 折射率 | 1.672 |
|
~%
28585-51-5 |
| 文献:Hatano, Akihiko; Kurosu, Masayuki; Yonaha, Susumu; Okada, Munehiro; Uehara, Sanae Organic and Biomolecular Chemistry, 2013 , vol. 11, # 40 p. 6900 - 6905 |
|
~59%
28585-51-5 |
| 文献:Hatano, Akihiko; Harano, Aiko; Kirihara, Masayuki Chemistry Letters, 2006 , vol. 35, # 2 p. 232 - 233 |